BELBUCA.com
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Raleigh, North Carolina, 27612, United S...Website
www.belbuca.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BELBUCA.com
BioDelivery Sciences International, Inc. specializes in the development and commercialization of innovative therapeutics for patients with severe and persistent pain. Their primary product, BELBUCA® (buprenorphine buccal film), is a long-acting opioid designed to manage pain when other treatments are inadequate. The company targets healthcare professionals and patients who require effective pain management solutions. They provide resources, safety information, and potential savings options for eligible patients.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BELBUCA.com your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BELBUCA.com recently announced quarterly report
Click to see if BELBUCA.com had a recent Job posting/layoffs
Product Launch: Get notified when BELBUCA.com launches new products
Check if BELBUCA.com has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at BELBUCA.com
Website visits: Recent activity has been detected on your website
Check out if BELBUCA.com is spiking on competitors!
Funding: Get notified immidiatlly once BELBUCA.com has new funding data
BELBUCA.com, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at BELBUCA.com
Find 2 more new buyers
Compare Similar Companies to BELBUCA.com
Compare insights from companies similar to BELBUCA.com, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BELBUCA.com
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
BELBUCA.com is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BELBUCA.com is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BELBUCA.com.
BELBUCA.com Tech Stack
A closer look at the technologies used by BELBUCA.com
BELBUCA.com News & Media
BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting
Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA® to Oxycodone on January 16 from 1:10pm – 2:10pm CTBioDelivery Sciences Announces Five Scientific Poster Presentations at PAINWeek® 2020 National Conference on Pain Management
New Scientific Information Further Highlights Differentiated Clinical Profile of BELBUCA® (buprenorphine buccal film) New Scientific Information Further Highlights Differentiated Clinical Profile of BELBUCA® (buprenorphine buccal film)BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic®
Major Pharmacy Benefit Manager (PBM) Improves Access for Both Products to Approximately 14 Million LivesBioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BELBUCA.com
Sign Up For FreeTo access detailed company insights
BioDelivery Sciences International, Inc. specializes in the development and commercialization of innovative therapeutics for patients with severe and persistent pain. Their primary product, BELBUCA® (buprenorphine buccal film), is a long-acting opioid designed to manage pain when other treatments are inadequate. The company targets healthcare profe... Read More
